- Home
- HAS vs BBIO Comparison
HAS vs BBIO Comparison
Compare HAS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- BBIO
- Stock Information
- Founded
- HAS 1923
- BBIO 2015
- Country
- HAS United States
- BBIO United States
- Employees
- HAS N/A
- BBIO N/A
- Industry
- HAS Recreational Games/Products/Toys
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- HAS Consumer Discretionary
- BBIO Health Care
- Exchange
- HAS Nasdaq
- BBIO Nasdaq
- Market Cap
- HAS 11.5B
- BBIO 9.4B
- IPO Year
- HAS N/A
- BBIO 2019
- Fundamental
- Price
- HAS $78.38
- BBIO $51.21
- Analyst Decision
- HAS Strong Buy
- BBIO Strong Buy
- Analyst Count
- HAS 11
- BBIO 16
- Target Price
- HAS $85.45
- BBIO $64.44
- AVG Volume (30 Days)
- HAS 1.3M
- BBIO 2.3M
- Earning Date
- HAS 10-23-2025
- BBIO 11-11-2025
- Dividend Yield
- HAS 3.57%
- BBIO N/A
- EPS Growth
- HAS N/A
- BBIO N/A
- EPS
- HAS N/A
- BBIO N/A
- Revenue
- HAS $4,250,800,000.00
- BBIO $235,812,000.00
- Revenue This Year
- HAS $7.56
- BBIO $115.49
- Revenue Next Year
- HAS $4.81
- BBIO $64.61
- P/E Ratio
- HAS N/A
- BBIO N/A
- Revenue Growth
- HAS N/A
- BBIO 7.62
- 52 Week Low
- HAS $49.00
- BBIO $21.72
- 52 Week High
- HAS $82.19
- BBIO $54.60
- Technical
- Relative Strength Index (RSI)
- HAS 47.05
- BBIO 52.92
- Support Level
- HAS $77.13
- BBIO $52.20
- Resistance Level
- HAS $80.11
- BBIO $54.60
- Average True Range (ATR)
- HAS 1.40
- BBIO 2.26
- MACD
- HAS -0.43
- BBIO -0.06
- Stochastic Oscillator
- HAS 24.70
- BBIO 56.48
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.